Ionis Pharmaceuticals Inc (NAS:IONS)

$ 38.315 -0.485 (-1.25%) Market Cap: 5.59 Bil Enterprise Value: 4.90 Bil PE Ratio: 0 PB Ratio: 18.87 GF Score: 70/100

Ionis Pharmaceuticals Inc at Piper Sandler Healthcare Conference (Virtual) Transcript

Dec 03, 2020 / NTS GMT

Release Date Price: $50.97 (-0.66%)

Transcript

Tyler Martin Van Buren

Piper Sandler & Co., Research Division - Principal & Senior Biotech Analyst

Hi there, everyone. My name is Tyler Van Buren, I'm a senior biotech analyst at Piper Sandler. Welcome to Piper's 32nd Annual Healthcare Conference. As this is our first time with a virtual format, we appreciate you all logging in. For this session, we're very pleased to have Ionis Pharmaceuticals here with us. And from Ionis, we have Brett Monia, the Chief Executive Officer; and Beth Hougen, the Chief Financial Officer.

So I figured we could start with a brief state of the union of the company and the description of the science behind the drugs for those who are less familiar, which by now, I'm sure it's not many. But also, it would be helpful to explain why you guys are so committed to the antisense technology and what indications it could be used for.

Brett P. Monia

Ionis Pharmaceuticals, Inc. - Founder, CEO & Director

Sure. Thank you very much, Tyler, and thank you for the invitation. It's a pleasure to be here. So yes, we're very excited

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.